Office Building


 New Rhein Fund 18 has invested in five companies developing proprietary drug/ device platforms for the treatment of COPD, BPH, COVID-19, etc. 


Past Deals

Prior investments have included medicines for Alzheimer’s disease, ophthalmic disorders, respiratory disease, and molecular oncology diagnostics.  

novagali logo.jfif

Novagali was a French ophthalmology

 company developing products for Dry Eye Disease and Glaucoma.  The company was acquired by Santen for $139M in 2011.